Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Growth Metrics

Others

Healthy Extracts (HYEX) Beginning Cash Balance (2023 - 2025)

Healthy Extracts filings provide 2 years of Beginning Cash Balance readings, the most recent being $20276.0 for Q4 2025.

On a quarterly basis, Beginning Cash Balance changed N/A to $20276.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $77455.0, a N/A change, with the full-year FY2025 number at $77455.0, changed N/A from a year prior.
Beginning Cash Balance hit $20276.0 in Q4 2025 for Healthy Extracts, up from $19655.0 in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $25000.0 in Q4 2023 to a low of $13402.0 in Q1 2025.